Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label trial of TMC207 in multidrug-resistant pulmonary tuberculosis
2008-008444-25Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bedaquiline in Tuberculosis (TB), sponsored by Johnson & Johnson. Primary endpoint: Median time to sputum conversion. Started Apr 2009; status: completed.
02
Drugs
bedaquiline
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on 2008-008444-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008444-25.